Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ZUBERITAMAB Cause Myelosuppression? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Myelosuppression have been filed in association with ZUBERITAMAB. This represents 20.0% of all adverse event reports for ZUBERITAMAB.

5
Reports of Myelosuppression with ZUBERITAMAB
20.0%
of all ZUBERITAMAB reports
0
Deaths
3
Hospitalizations

How Dangerous Is Myelosuppression From ZUBERITAMAB?

Of the 5 reports, 3 (60.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.

Is Myelosuppression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ZUBERITAMAB. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ZUBERITAMAB Cause?

Lymphocyte count decreased (10) Neutrophil count decreased (9) White blood cell count decreased (7)

What Other Drugs Cause Myelosuppression?

CYCLOPHOSPHAMIDE (3,603) CARBOPLATIN (2,624) TRASTUZUMAB (2,552) PACLITAXEL (2,522) TISLELIZUMAB (2,142) CYTARABINE (1,869) VENETOCLAX (1,864) CISPLATIN (1,849) BEVACIZUMAB (1,744) SODIUM (1,696)

Related Pages

ZUBERITAMAB Full Profile All Myelosuppression Reports All Drugs Causing Myelosuppression ZUBERITAMAB Demographics